CD40 and B-cell chronic lymphocytic leukemia: For example, a CD40-specific bispecific antibody effectively redirected Vγ9Vδ2 T cells to kill tumor cells while simultaneously blocking the pro-survival signaling of CD40, resulting in prolonged survival in mouse models of CLL.